Lunit

About Lunit

Lunit is a company focused on conquering cancer through AI technology. Their mission is to save lives by leveraging AI for early cancer detection and improving treatment efficacy with AI biomarkers for immunotherapy.

Products & Services

Lunit INSIGHT CXR:AI solution for chest X-ray analysis to detect early-stage cancers.

Lunit INSIGHT CXR Triage:AI tool for prioritizing chest X-ray cases based on urgency.

Lunit INSIGHT DBT:AI tool for digital breast tomosynthesis for enhanced cancer screening.

Lunit SCOPE IO:AI biomarker solution for immunotherapy in oncology.

Lunit SCOPE PD-L1:AI tool for predicting PD-L1 expression in cancer treatment.

Lunit SCOPE uIHC:AI solution for universal immunohistochemistry analysis.

Specialties

Artificial Intelligence Cancer Detection Cancer Treatment Immunotherapy Biomarkers Precision Oncology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Capital Increase T: - FT: Capital Increase	A: 150000000 MR: - FA: $150 million FAN: 150000000	D: 2023-11-15 FD: 2023-11-15	1 investors

Capital Increase Latest

2023-11-15

$150.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

B

Beomseok Brandon Suh

Chief Executive Officer

A

Anthony Paek

Co-founder, Executive Chairman

H

Hyeonseong Park

Chief Financial Officer

D

Donggeun Yoo

Co-founder, Chief AI Officer, Technology Innovation Group

S

Sunggyun Park

Co-founder, Chief Product, and Regulation Division Officer

K

Kihwan Kim

Group Head of Cancer Screening Group

View 21 more team members with Pro

Unlock Full Team Directory

Recent News

Lunit Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised